Zosano Pharma Corporation (ZSAN) Stock Analyst Ratings

NASDAQ:ZSAN • US98979H3012

0.5576
+0.04 (+7.23%)
At close: Jun 10, 2022
0.5459
-0.01 (-2.1%)
After Hours: 6/10/2022, 8:00:56 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

46

ChartMill assigns a Buy % Consensus number of 46% to ZSAN. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 21.42. This target is 3741.46% above the current price.
  • ZSAN was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about ZSAN.
  • In the last month the buy percentage fell by 34 points. So the trust of analysts is decreasing.
  • ZSAN was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
ZSAN Historical Analyst RatingsZSAN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 0.5621.2121.4221.4222.05 - 3,703.80% 3,741.46% 3,741.46% 3,854.45%

Related screens

Find peers 30% below price target
ZSAN Current Analyst RatingZSAN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2022-02-23 BTIG Downgrade Buy -> Neutral
2021-03-15 Maxim Group Maintains Buy

Zosano Pharma Corporation / ZSAN FAQ

Can you provide the average price target for Zosano Pharma Corporation stock?

7 analysts have analysed ZSAN and the average price target is 21.42 null. This implies a price increase of 3741.46% is expected in the next year compared to the current price of 0.5576.


What is the consensus rating for ZSAN stock?

The consensus rating for Zosano Pharma Corporation (ZSAN) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.